Save up to 65% until 2/29! Learn more here

Questions? Call Now: (404) 998-5012

Cord Blood Uses
Diseases Treated

Cord blood is a rich source of newborn stem cells that has over the last 30 years been used in successful FDA-approved treatments for more than 80 serious diseases to replace damaged blood and immune systems with healthy cells.

FDA approved, proven transplant medicine uses:

  • Acute Biphenotypic Leukemia
  • Acute Lymphocytic Leukemia (ALL)
  • Acute Myelogenous Leukemia (AML)
  • Acute Undifferentiated Leukemia
  • Juvenile Myelomonocytic Leukemia (JMML)
  • Adult T Cell Leukemia/Lymphoma
  • Chronic Active Epstein Barr
  • Ewing Sarcoma
  • Hodgkin’s Lymphoma
  • Non-Hodgkin’s Lymphoma
  • Juvenile Chronic Myelogenous Leukemia (JCML)
  • Prolymphocytic Leukemia
  • Plasma Cell Leukemi
  • Leukocyte Adhesion Deficiency
  • Multiple Myeloma
  • Neuroblastoma
  • Myeloid/Natural Killer (NK) Cell PrecursorAcute Leukemia
  • Rhabdomyosarcoma
  • Thymoma (Thymic Carcinoma)
  • Waldenstrom’s Macroglobulinemia
  • Wilms Tumor
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia (CML)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Bare Lymphocyte Syndrome (SCID)
  • Chediak-Higashi Syndrome (SCID)
  • Chronic Granulomatous Disease
  • Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) Syndrome
  • Congenital Neutropenia
  • DiGeorge Syndrome
  • Evans Syndrome
  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Fucosidosis
  • Kostmann Syndrome (SCID)
  • Hemophagocytosis Langerhans’ Cell Histiocytosis (Histiocytosis X)
  • Myelokathexis
  • Omenn Syndrome (SCID)
  • Phosphorylase Deficiency (SCID)
  • Purine Nucleoside (SCID)
  • Severe Combined Immunodeficiency Diseases (SCID)
  • Reticular Dysgenesis (SCID)
  • IKK Gamma Deficiency (NEMO Deficiency)
  • Thymic Dysplasia
  • Wiskott-Aldrich Syndrome
  • X-linked Agammaglobulinemia
  • X-Linked Hyper IgM Syndrome
  • Adenosine Deaminase Deficiency (SCID)
  • X-Linked Lymphoproliferative Disorder
  • Gaucher Disease
  • Hunter Syndrome (MPS-II)
  • Hurler Syndrome (MPS-IH)
  • Krabbe Disease
  • Neuronal Ceroid Lipofuscinosis (Batten Disease)
  • Lesch-Nyhan Syndrome
  • Mannosidosis
  • Maroteaux-Lamy Syndrome (MPS-VI)
  • Metachromatic Leukodystrophy
  • Mucolipidosis II (I-cell Disease)
  • Niemann-Pick Disease
  • Sandhoff Disease
  • Congenital Erythropoietic Porphyria (Gunther Disease)
  • Sanfilippo Syndrome (MPS-III)
  • Scheie Syndrome (MPS-IS)
  • Sly Syndrome (MPS-VII)
  • Tay Sachs
  • Wolman Disease
  • X-Linked Adrenoleukodystrophy
  • Acute Myelofibrosis
  • Amyloidosis
  • Congenital Amegakaryocytic Thrombocytopenia (CAT)
  • Aplastic Anemia (Severe)
  • Beta Thalassemia Major
  • Blackfan-Diamond Anemia
  • Congenital Cytopenia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Dyskeratosis Congenita
  • Essential Thrombocythemia
  • Fanconi Anemia
  • Congenital Dyserythropoietic Anemia
  • Refractory Anemia with Excess Blasts in Transition (RAEB-T)
  • Glanzmann’s Thrombasthenia
  • Myelodysplastic Syndrome
  • Polycythemia Vera
  • Refractory Anemia with Ringed Sideroblasts (RARS)
  • Pure Red Cell Aplasia
  • Shwachman-Diamond Syndrome
  • Sickle Cell Disease
  • Agnogenic Myeloid Metaplasia

The Power of
Regenerative Medicine

As cord blood stem cell research advances, so does the potential for future uses. Experimental therapies that may not have seemed possible 15 years ago are being explored today in FDA regulated clinical trials. Regenerative medicine is an emerging field of medicine that aims to replace, repair, and regenerate human cells, tissues, or organs lost or injured due to age, disease, or congenital defects to restore or establish normal function in areas of research within regenerative medicine:

  • Autoimmune
  • Cardiovascular
  • Neurological (Acquired)
  • Neurological (Degenerative)
  • Orthopedic
  • Tissue or organ damage

The Lifesaving Power in Stem Cells

Stem cell science has the potential to make a lasting impact on your family. What we know about stem cells continues to evolve, with each discovery fueling research into new applications. These trials represent a new, exciting age in umbilical cord blood and tissue research. It’s estimated that 1 in 3 people will benefit from regenerative medicine in their lifetime.

Ready To Store?

For nearly two decades, AlphaCord has worked with tens of thousands of families to preserve their newborn’s valuable stem cells through cord blood and tissue banking. You only have one chance to save your baby’s stem cells. Take advantage of this once-in-a-lifetime opportunity.

Order Now
Sleeping baby laying on blankets holding a stuffed rabbit.